These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28157467)

  • 1. Tuberculosis case finding and mortality prediction: added value of the clinical TBscore and biomarker suPAR.
    Rudolf F; Wagner AJ; Back FM; Gomes VF; Aaby P; Østergaard L; Eugen-Olsen J; Wejse C
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):67-72. PubMed ID: 28157467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sedimentation rate and suPAR in relation to disease activity and mortality in patients with tuberculosis.
    Schulman H; Niward K; Abate E; Idh J; Axenram P; Bornefall A; Forsgren S; Jakobsson J; Öhrling C; Kron M; Brudin L; Diro E; Getachew Kebede A; Paues J; Bruchfeld J; Wejse C; Stendahl O; Schön T
    Int J Tuberc Lung Dis; 2019 Nov; 23(11):1155-1161. PubMed ID: 31718751
    [No Abstract]   [Full Text] [Related]  

  • 3. Can tuberculosis case finding among health-care seeking adults be improved? Observations from Bissau.
    Rudolf F; Haraldsdottir TL; Mendes MS; Wagner AJ; Gomes VF; Aaby P; Østergaard L; Eugen-Olsen J; Wejse C
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):277-85. PubMed ID: 24670561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of soluble urokinase plasminogen activator receptor (suPAR) as a marker of tuberculosis treatment efficacy.
    Indumati V; Vijay V; Krishnaswamy D; Rajeshwari V; Ramesh A; Shantala D; Shilpa A
    Indian J Tuberc; 2017 Jul; 64(3):206-211. PubMed ID: 28709490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High mortality risk among individuals assumed to be TB-negative can be predicted using a simple test.
    Rabna P; Andersen A; Wejse C; Oliveira I; Gomes VF; Haaland MB; Aaby P; Eugen-Olsen J
    Trop Med Int Health; 2009 Sep; 14(9):986-94. PubMed ID: 19725925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bandim TBscore--reliability, further development, and evaluation of potential uses.
    Rudolf F
    Glob Health Action; 2014; 7():24303. PubMed ID: 24857613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau.
    Eugen-Olsen J; Gustafson P; Sidenius N; Fischer TK; Parner J; Aaby P; Gomes VF; Lisse I
    Int J Tuberc Lung Dis; 2002 Aug; 6(8):686-92. PubMed ID: 12150480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment.
    Rabna P; Andersen A; Wejse C; Oliveira I; Gomes VF; Haaland MB; Aaby P; Eugen-Olsen J
    PLoS One; 2012; 7(8):e43933. PubMed ID: 22937128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble urokinase-type plasminogen activator receptor as a biomarker of treatment response in childhood tuberculosis.
    Olivianto E; Sudarwati S; Nataprawira HM
    Int J Mycobacteriol; 2019; 8(3):262-266. PubMed ID: 31512602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year follow-up of patients with pulmonary tuberculosis in Guinea-Bissau, West Africa.
    Winqvist N; Nauclér A; Gomes V; Djamanca I; Koivula T; Jensen H; Dias F; Biberfeld G; Källenius G; Norberg R
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):845-52. PubMed ID: 10985653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing gender differences among presumed and diagnosed patients with pulmonary TB: observations from Guinea-Bissau.
    Bohlbro AS; Mendes AM; Sifna A; Patsche CB; Gomes V; Wejse C; Rudolf F
    Trans R Soc Trop Med Hyg; 2021 Nov; 115(11):1273-1281. PubMed ID: 34542154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD.
    Godtfredsen NS; Jørgensen DV; Marsaa K; Ulrik CS; Andersen O; Eugen-Olsen J; Rasmussen LJH
    Respir Res; 2018 May; 19(1):97. PubMed ID: 29783959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments.
    Alstrup M; Meyer J; Schultz M; Rasmussen LJH; Rasmussen LS; Køber L; Forberg JL; Eugen-Olsen J; Iversen K
    World J Surg; 2019 Mar; 43(3):780-790. PubMed ID: 30390135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of HIV-1, HIV-2, and HIV-1+2 dual infection on the outcome of tuberculosis.
    Wejse C; Patsche CB; Kühle A; Bamba FJ; Mendes MS; Lemvik G; Gomes VF; Rudolf F
    Int J Infect Dis; 2015 Mar; 32():128-34. PubMed ID: 25499041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
    Rasmussen LJ; Ladelund S; Haupt TH; Ellekilde G; Poulsen JH; Iversen K; Eugen-Olsen J; Andersen O
    Emerg Med J; 2016 Nov; 33(11):769-775. PubMed ID: 27590986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble urokinase plasminogen activator receptor as a prognostic marker of all-cause and cardiovascular mortality in a black population.
    Botha S; Fourie CMT; Schutte R; Eugen-Olsen J; Pretorius R; Schutte AE
    Int J Cardiol; 2015 Apr; 184():631-636. PubMed ID: 25771228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TBscore II: refining and validating a simple clinical score for treatment monitoring of patients with pulmonary tuberculosis.
    Rudolf F; Lemvik G; Abate E; Verkuilen J; Schön T; Gomes VF; Eugen-Olsen J; Østergaard L; Wejse C
    Scand J Infect Dis; 2013 Nov; 45(11):825-36. PubMed ID: 24041274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
    Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
    Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study.
    Rasmussen LJH; Ladelund S; Haupt TH; Ellekilde GE; Eugen-Olsen J; Andersen O
    Crit Care Med; 2018 Dec; 46(12):1961-1968. PubMed ID: 30247244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis.
    Wejse C; Furtado A; Camara C; Lüneborg-Nielsen M; Sodemann M; Gerstoft J; Katzenstein TL
    Int J Infect Dis; 2013 Oct; 17(10):e907-12. PubMed ID: 23816410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.